ASURAGEN, INC.
AcquiredMolecular Diagnostics, Genetics & Oncology Testing
AUSTIN, United States · Founded 2015 · $80.0M raised
- Headquarters
- AUSTIN, Texas
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- asuragen.com
- Total Funding
- $80.0M
- Last Round
- $18.5M GrantJan 2015
About
Asuragen is a molecular diagnostic product company focused on genetics and oncology testing. It develops PCR-based and next-generation sequencing kits for detecting genetic mutations associated with conditions such as spinal muscular atrophy, Huntington's disease, and chronic myeloid leukemia. Asuragen operates as a brand under Bio-Techne Corporation following an acquisition.
Summary
ASURAGEN, INC. is a Biotech company based in AUSTIN, United States, founded in 2015. It has raised $80.0M in total, most recently a $18.5M Grant round in Jan 2015.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...